Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alkermes Plc (NQ: ALKS )

31.87 +0.44 (+1.40%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 6, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,966,363
Open 31.57
Bid (Size) 31.90 (1)
Ask (Size) 32.23 (1)
Prev. Close 31.43
Today's Range 30.61 - 32.13
52wk Range 21.24 - 33.00
Shares Outstanding 163,426,943
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sarissa Capital Comments on Alkermes Annual Meeting
From Sarissa Capital Management LP
Via Business Wire
Northrop Grumman Leads 5 Defensive Plays Near Buy Points
Northrop headlines 5 stocks near buy points with the mettle to withstand a recession. 
Via Investor's Business Daily

Performance

YTD
+31.97%
+31.97%
1 Month
+12.46%
+12.46%
3 Month
+11.55%
+11.55%
6 Month
+37.73%
+37.73%
1 Year
+24.69%
+24.69%

More News

Read More
Day One Biopharmaceuticals Stock Scores Rising Relative Strength Upgrade
Via Investor's Business Daily
4 Biotech Stocks With Bright Prospects To Buy Amid Recovery
Via Talk Markets
Alkermes Announces 2022 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer
Via 3BL Media
Recap: Alkermes Q1 Earnings
Via Benzinga
Small-Cap Psychedelic Play Vying for Future Leadership in Addiction Treatment (AXSM, AWKNF, BICX, OPNT, ALKS, PFE, AMPH, OMER)
Via AB Newswire
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
Via Benzinga
Best Stocks To Buy Now: June 02, 2022
Via Best Stocks
Topics Artificial Intelligence Cannabis
Exposures Artificial Intelligence Cannabis
Sarissa Condemns Poor Corporate Governance at Alkermes
From Sarissa Capital Management LP
Via Business Wire
New Findings About Life With Bipolar 1 Disorder
Via 3BL Media
Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028
Via FinancialNewsMedia
Exposures COVID-19
Treating Bipolar 1 Disorder
Via 3BL Media
Top Biotech Stocks: Trading Opportunities For Next Week - Sunday, May 22
Via Talk Markets
Alkermes Awarded 2022 Platinum Bell Seal for Workplace Mental Health
Via 3BL Media
Tips to Improve Mental Well-Being
Via 3BL Media
Alkermes Celebrates National Women's Health Week by Reminding You Why Regular Cancer Screenings Are Vital
Via 3BL Media
Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness Month
Via 3BL Media
Looking Into Alkermes's Return On Capital Employed
Via Benzinga
61 Biggest Movers From Yesterday
Via Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
LGBTQ+ People Are More Likely to Experience a Mental Health Condition
Via 3BL Media
Topics LGBTQ
Exposures Diversity
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
Via Benzinga
Alkermes's Earnings Outlook
Via Benzinga
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.